• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Synthesis of 2'-Deoxy-1'-homo-N-nucleosides with Anti-Influenza Activity by Catalytic Methyltrioxorhenium (MTO)/H(2) O(2) Oxyfunctionalization

tetano

Editor, Senior Moderator
Chemistry. 2012 Dec 6. doi: 10.1002/chem.201201285. [Epub ahead of print]
Synthesis of 2'-Deoxy-1'-homo-N-nucleosides with Anti-Influenza Activity by Catalytic Methyltrioxorhenium (MTO)/H(2) O(2) Oxyfunctionalization.
Saladino R, Neri V, Checconi P, Celestino I, Nencioni L, Palamara AT, Crucianelli M.
Source

Department of Agrobiology and Agrochemistry, University of Tuscia, via S. Camillo de Lellis, I-01100 Viterbo (Italy), Fax: (+39) 0761-357242. saladino@unitus.it.
Abstract

This paper describes a new route for the synthesis of 1'-homo-N-nucleoside derivatives by means of either methyltrioxorhenium (MTO) or supported MTO catalysts, with H(2) O(2) as the primary oxidant. Under these selective conditions, the oxyfunctionalization of the heterocyclic ring and the N heteroatom oxidation were operative processes, regardless of the type of substrate used, that is, purine or pyrimidine derivatives. In addition, the oxidation of 1'-homo-N-thionucleosides, showed the occurrence of site-specific oxidative nucleophilic substitutions of the heterocyclic ring. The MTO/H(2) O(2) system showed, in general, high reactivity under both homogeneous and heterogeneous conditions, affording the final products with high conversion values of substrates and from medium to high yields. Many of the novel 1'-homo-N-nucleoside analogues were active against the influenza A virus, without any cytotoxic effects, retaining their activity in both protected and unprotected forms.

Copyright ? 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

PMID:
23225323
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23225323
 
Back
Top Bottom